'I feel very good,' says Mr. Gong, a 57-year-old man from Shanghai who experienced remarkable recoveries from systemic sclerosis just days after receiving CRISPR-modified immune cells.
Researchers aim to create CAR T therapies using donor cells, which could drastically reduce costs and manufacturing times, enabling treatments for hundreds instead of one.
The study signifies a breakthrough in using bioengineered immune cells for autoimmune conditions, overcoming the personalization challenges of traditional CAR T therapies.
This advance in treatment marks the first instance of individuals with autoimmune disorders receiving engineered immune cells derived from donors, setting a precedent for future therapies.
#autoimmune-disorders #car-t-cell-therapy #crispr-technology #medical-breakthroughs #stem-cell-research
Collection
[
|
...
]